Graphical Abstract Similar content being viewed by others Introduction Immunomodulation is transforming the treatment landscape of type 1 diabetes [1, 2]
Directly supplementing with oral reduced glutathione (L-GSH), however, presents a fundamental pharmacokinetic challenge: GSH has a plasma half-life of approximately 1.6 minutes, undergoes rapid hydrolysis in the gut by intestinal -glutamyl transpeptidase (-GT), and cannot cross cell membranes intact requiring full breakdown into constituent amino acids and intracellular resynthesis
It is commonly used for detecting single-strand breaks (SSBs), double-strand breaks (DSBs), and alkali-labile sites (Gonzalez-Hunt et al., 2018
In 2019, the California State Board of Pharmacy received a complaint that Empower was sending residents a vitamin C injectable that was a copy of an FDA approved medication and therefore not eligible for compounding, according to public pharmacy board documents
and Beckman, J.S